Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection - PubMed (original) (raw)
Multicenter Study
doi: 10.1007/s00134-010-2078-z. Epub 2010 Nov 24.
T Lisboa, A Rhodes, R P Moreno, E Silva, C Sprung, J D Chiche, D Barahona, M Villabon, C Balasini, R M Pearse, R Matos, J Rello; ESICM H1N1 Registry Contributors
Collaborators, Affiliations
- PMID: 21107529
- PMCID: PMC7079858
- DOI: 10.1007/s00134-010-2078-z
Multicenter Study
Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection
I Martin-Loeches et al. Intensive Care Med. 2011 Feb.
Abstract
Introduction: Early use of corticosteroids in patients affected by pandemic (H1N1)v influenza A infection, although relatively common, remains controversial.
Methods: Prospective, observational, multicenter study from 23 June 2009 through 11 February 2010, reported in the European Society of Intensive Care Medicine (ESICM) H1N1 registry.
Results: Two hundred twenty patients admitted to an intensive care unit (ICU) with completed outcome data were analyzed. Invasive mechanical ventilation was used in 155 (70.5%). Sixty-seven (30.5%) of the patients died in ICU and 75 (34.1%) whilst in hospital. One hundred twenty-six (57.3%) patients received corticosteroid therapy on admission to ICU. Patients who received corticosteroids were significantly older and were more likely to have coexisting asthma, chronic obstructive pulmonary disease (COPD), and chronic steroid use. These patients receiving corticosteroids had increased likelihood of developing hospital-acquired pneumonia (HAP) [26.2% versus 13.8%, p < 0.05; odds ratio (OR) 2.2, confidence interval (CI) 1.1-4.5]. Patients who received corticosteroids had significantly higher ICU mortality than patients who did not (46.0% versus 18.1%, p < 0.01; OR 3.8, CI 2.1-7.2). Cox regression analysis adjusted for severity and potential confounding factors identified that early use of corticosteroids was not significantly associated with mortality [hazard ratio (HR) 1.3, 95% CI 0.7-2.4, p = 0.4] but was still associated with an increased rate of HAP (OR 2.2, 95% CI 1.0-4.8, p < 0.05). When only patients developing acute respiratory distress syndrome (ARDS) were analyzed, similar results were observed.
Conclusions: Early use of corticosteroids in patients affected by pandemic (H1N1)v influenza A infection did not result in better outcomes and was associated with increased risk of superinfections.
Figures
Fig. 1
Survival graph for patients with severe pandemic (H1N1)v influenza A infection with or without early corticosteroid therapy on ICU admission (censored at 60 days)
Comment in
- Early steroid therapy for patients with H1N1 influenza A virus infection.
Petros AJ, Rommes JH, Silvestri L, Taylor N, van Saene HK. Petros AJ, et al. Intensive Care Med. 2011 Sep;37(9):1563-4; author reply 1565. doi: 10.1007/s00134-011-2289-y. Epub 2011 Jun 21. Intensive Care Med. 2011. PMID: 21691885 Free PMC article. No abstract available.
Similar articles
- Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza.
Diaz E, Martin-Loeches I, Canadell L, Vidaur L, Suarez D, Socias L, Estella A, Gil Rueda B, Guerrero JE, Valverdú-Vidal M, Vergara JC, López-Pueyo MJ, Magret M, Recio T, López D, Rello J, Rodriguez A; H1N1 SEMICYUC-CIBERES-REIPI Working Group (GETGAG). Diaz E, et al. J Infect. 2012 Mar;64(3):311-8. doi: 10.1016/j.jinf.2011.12.010. Epub 2012 Jan 2. J Infect. 2012. PMID: 22240033 - Corticosteroids as adjunctive therapy in the treatment of influenza.
Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Lansbury L, et al. Cochrane Database Syst Rev. 2019 Feb 24;2(2):CD010406. doi: 10.1002/14651858.CD010406.pub3. Cochrane Database Syst Rev. 2019. PMID: 30798570 Free PMC article. - First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain.
Rodríguez A, Martin-Loeches I, Bonastre J, Olaechea P, Alvarez-Lerma F, Zaragoza R, Guerrero J, Blanco J, Gordo F, Pozo F, Lorente J, Carratalá J, Cordero M, Rello J, Esteban A, León C; SEMICYUC-CIBERES-REIPI working group. Rodríguez A, et al. Med Intensiva. 2011 May;35(4):208-16. doi: 10.1016/j.medin.2011.03.001. Epub 2011 Apr 14. Med Intensiva. 2011. PMID: 21496964 - Corticosteroids as adjunctive therapy in the treatment of influenza.
Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Rodrigo C, et al. Cochrane Database Syst Rev. 2016 Mar 7;3:CD010406. doi: 10.1002/14651858.CD010406.pub2. Cochrane Database Syst Rev. 2016. PMID: 26950335 Updated. Review. - Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis.
Yang JW, Fan LC, Miao XY, Mao B, Li MH, Lu HW, Liang S, Xu JF. Yang JW, et al. Clin Microbiol Infect. 2015 Oct;21(10):956-63. doi: 10.1016/j.cmi.2015.06.022. Epub 2015 Jun 27. Clin Microbiol Infect. 2015. PMID: 26123860 Review.
Cited by
- Secondary infections in critically ill patients with COVID-19 receiving steroid therapy.
Pearce AK, Zawaydeh Q, McGuire WC, Husain A, Ayoub C, Sweeney DA, Cotton SA, Malhotra A. Pearce AK, et al. Sci Prog. 2023 Oct-Dec;106(4):368504231207209. doi: 10.1177/00368504231207209. Sci Prog. 2023. PMID: 37899703 Free PMC article. - Is COVID-19 different from other causes of acute respiratory distress syndrome?
Beloncle FM. Beloncle FM. J Intensive Med. 2023 Apr 11;3(3):212-9. doi: 10.1016/j.jointm.2023.02.003. Online ahead of print. J Intensive Med. 2023. PMID: 37362866 Free PMC article. Review. - Trends in research on acute lung injury/acute respiratory distress syndrome associated with viral pneumonia from 1992 to 2022: a 31-year bibliometric analysis.
Zhang L, Mei S, Zhu B, Zhao Z. Zhang L, et al. Front Med (Lausanne). 2023 Jun 9;10:1158519. doi: 10.3389/fmed.2023.1158519. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37359015 Free PMC article. - Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials.
Bouras M, Rello J, Roquilly A. Bouras M, et al. Anaesth Crit Care Pain Med. 2023 Aug;42(4):101253. doi: 10.1016/j.accpm.2023.101253. Epub 2023 May 26. Anaesth Crit Care Pain Med. 2023. PMID: 37245688 Free PMC article. No abstract available. - Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.
Peral J, Estella Á, Nuvials X, Rodríguez A, Seijas I, Soriano C, Suberviola B, Zaragoza R. Peral J, et al. J Fungi (Basel). 2023 Mar 2;9(3):312. doi: 10.3390/jof9030312. J Fungi (Basel). 2023. PMID: 36983480 Free PMC article.
References
- Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A, Guerrero J, Ruiz-Santana S, Marquez E, Del Nogal-Saez F, Alvarez-Lerma F, Martínez S, Ferrer M, Avellanas M, Granada R, Maraví-Poma E, Albert P, Sierra R, Vidaur L, Ortiz P, Prieto del Portillo I, Galván B, León-Gil C: H1N1 SEMICYUC Working Group Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148. doi: 10.1186/cc8044. - DOI - PMC - PubMed
- Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA: Canadian Critical Care Trials Group H1N1 Collaborative Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–1879. doi: 10.1001/jama.2009.1496. - DOI - PubMed
- Estenssoro E, Ríos FG, Apezteguía C, Reina R, Neira J, Ceraso DH, Orlandi C, Valentini R, Tiribelli N, Brizuela M, Balasini C, Mare S, Domeniconi G, Ilutovich S, Gomez A, Giuliani J, Barrios C, Valdez P (2010) Pandemic 2009 Influenza A(H1N1) in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. doi:10.1164/rccm.201001-0037OC - PubMed